We are live on ! Find out more
Skandinaviska Enskilda Banken (SEB)

Skandinaviska Enskilda Banken (SEB) Portfolio holdings

AUM $2.66B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+26.2%
3 Year Est. Return
+111.17%
5 Year Est. Return
+154.66%
10 Year Est. Return
+614.64%
AUM
$20.8B
AUM Growth
+$384M
Cap. Flow
-$386M
Cap. Flow %
-1.85%
Top 10 Hldgs %
36.66%
Holding
834
New
50
Increased
348
Reduced
209
Closed
64

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$320M
2
PGR icon
Progressive
PGR
+$112M
3
CI icon
Cigna
CI
+$105M
4
QCOM icon
Qualcomm
QCOM
+$90.6M
5
JPM icon
JPMorgan Chase
JPM
+$73.4M

Sector Composition

Rank Sector Weight
1 Technology 38.73%
2 Healthcare 17.07%
3 Financials 10.41%
4 Consumer Discretionary 9.88%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCL
626
DELISTED
Stericycle Inc
SRCL
$1.16M 0.01%
+20,000
New +$1.03M
RVMD icon
627
Revolution Medicines
RVMD
$44B
$1.15M 0.01%
29,705
IDYA icon
628
IDEAYA Biosciences
IDYA
$3.56B
$1.14M 0.01%
32,544
KYMR icon
629
Kymera Therapeutics
KYMR
$9.48B
$1.14M 0.01%
38,141
MBLY icon
630
Mobileye
MBLY
$7.48B
$1.13M 0.01%
40,257
+14,300
+55% +$414K
GTLB icon
631
GitLab
GTLB
$6.89B
$1.12M 0.01%
+22,409
New +$1.16M
HTHT icon
632
Huazhu Hotels Group
HTHT
$12.7B
$1.11M 0.01%
33,400
-90,700
-73% -$3.42M
BEN icon
633
Franklin Resources
BEN
$17.1B
$1.11M 0.01%
49,545
KURA icon
634
Kura Oncology
KURA
$882M
$1.11M 0.01%
53,738
PARA
635
DELISTED
Paramount Global Class B
PARA
$1.09M 0.01%
104,904
+5,400
+5% +$63.2K
ADTN icon
636
Adtran
ADTN
$665M
$1.07M 0.01%
204,261
+36,371
+22% +$185K
PAAS icon
637
Pan American Silver
PAAS
$22.1B
$1.06M 0.01%
53,557
+328
+0.6% +$6.46K
GIL icon
638
Gildan
GIL
$10.6B
$1.06M 0.01%
27,901
BIO icon
639
Bio-Rad Laboratories Class A
BIO
$9.68B
$1.05M 0.01%
3,831
LUV icon
640
Southwest Airlines
LUV
$22B
$1.01M ﹤0.01%
35,405
ITRI icon
641
Itron
ITRI
$4.49B
$1.01M ﹤0.01%
10,207
+5,047
+98% +$508K
DNLI icon
642
Denali Therapeutics
DNLI
$4.04B
$1M ﹤0.01%
43,245
JANX icon
643
Janux Therapeutics
JANX
$1.02B
$989K ﹤0.01%
23,617
ACLS icon
644
Axcelis
ACLS
$4.39B
$983K ﹤0.01%
6,902
+1,039
+18% +$120K
APLS
645
DELISTED
Apellis Pharmaceuticals
APLS
$982K ﹤0.01%
25,581
SHLS icon
646
Shoals Technologies Group
SHLS
$1.4B
$980K ﹤0.01%
157,000
+93,400
+147% +$745K
FDMT icon
647
4D Molecular Therapeutics
FDMT
$621M
$936K ﹤0.01%
44,600
ABCL icon
648
AbCellera Biologics
ABCL
$3.18B
$913K ﹤0.01%
308,567
+158,000
+105% +$598K
IOVA icon
649
Iovance Biotherapeutics
IOVA
$3.05B
$912K ﹤0.01%
113,952
GRAB icon
650
Grab
GRAB
$14.7B
$869K ﹤0.01%
244,903
+110
+0% +$386

Similar funds

Skandinaviska Enskilda Banken (SEB)'s Q2 2024 Portfolio in Review

As of Q2 2024, Skandinaviska Enskilda Banken (SEB) held 834 positions worth $20.8B, up 1.9% from $20.4B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Skandinaviska Enskilda Banken (SEB)'s Q2 2024 filing shows 50 new, 348 increased, 209 reduced and 64 closed positions. Its largest new stake was Penumbra: 64,782 shares worth $11.7M. The largest sale was Alphabet (Google) Class A, an estimated $310M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Skandinaviska Enskilda Banken (SEB)'s largest Q2 2024 buy was Penumbra: 64,782 shares worth $11.7M.
  • Skandinaviska Enskilda Banken (SEB) added most to Microsoft in Q2 2024, an estimated $320M increase.
  • Skandinaviska Enskilda Banken (SEB)'s biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $310M.
  • Skandinaviska Enskilda Banken (SEB) fully exited GE Aerospace in Q2 2024, selling an estimated $63M.
  • Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 37% of its $20.8B portfolio in Q2 2024.
  • Skandinaviska Enskilda Banken (SEB) opened 50 new positions and closed 64 in Q2 2024.
  • Skandinaviska Enskilda Banken (SEB)'s portfolio value rose 1.9% quarter-over-quarter to $20.8B.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2024, filed 13 Aug 2024.